-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare
Overview ( as on 28/03/25 )
NAV
₹36.2
Last change
₹0.0 +0.0%
Fund Size (AUM)
4611.47 Cr
Performance
31.57% (5Y)
Fund Details
ICICI Pru Pharma Healthcare Diag Gr
as of 28/03/25
AUM
4611.47 Cr
Expense Ratio
1.94 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Pru Pharma Healthcare Diag Gr | 19.87% | 22.8% | 31.57% |
| BSE Healthcare TR INR | 18.17% | 19.45% | 27.8% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.21% |
Cipla Ltd |
9.55% |
Dr Reddy's Laboratories Ltd |
8.94% |
Divi's Laboratories Ltd |
6.78% |
Aurobindo Pharma Ltd |
5.15% |
Lupin Ltd |
4.73% |
Alkem Laboratories Ltd |
4.49% |
Gland Pharma Ltd |
3.52% |
Zydus Lifesciences Ltd |
3.27% |
Mankind Pharma Ltd |
2.85% |
Sector Allocation
Healthcare |
91.33% |
Basic Materials |
5.83% |
Financial |
2.85% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
30.48% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
30.48% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.57% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.69% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
29.44% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
28.51% (5Y)
-
